ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 239,71
-0,78%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Equillium Inc (EQ)

  7. Equillium Inc (EQ) Actualités

EQ Equillium Inc

1,71
-0,10 (-5,52%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Equillium Inc EQ NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,10 -5,52% 1,71 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,85 1,69 1,85 1,71 1,81
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/4/202414:00BWEquillium Reports Inducement Grant Under Nasdaq Listing Rule..
01/4/202414:00BWEquillium Announces Positive Topline Data from the Type B..
25/3/202421:01BWEquillium Reports on Fourth Quarter and Full Year 2023..
22/3/202413:00BWEquillium to Present at the H.C. Wainwright Autoimmune &..
08/3/202423:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/3/202422:01EDGAR2Form 8-K - Current report
23/2/202423:12EDGAR2Form 8-K - Current report
23/2/202423:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/2/202412:08EDGAR2Form 8-K - Current report
04/1/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202314:05EDGAR2Form 8-K - Current report
21/12/202314:00BWEquillium Announces Update on Multi-Cytokine Inhibitors..
20/11/202317:23PRNCAEQ Bank Card launches in Québec as Carte Banque EQ
13/11/202315:00BWEquillium Presents Positive Data from Phase 1b EQUALISE..
08/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:05EDGAR2Form 8-K - Current report
08/11/202322:01BWEquillium Reports Third Quarter 2023 Financial Results and..
06/11/202314:00BWEquillium Announces Data from Phase 1b EQUALISE Study..
19/10/202314:00BWEquillium Announces Abstracts Accepted for Presentation at..
16/10/202314:05EDGAR2Form 8-K - Current report
16/10/202314:00BWEquillium Announces Preclinical Data from New Orally..
05/10/202323:28EDGAR2Form 8-K - Current report
05/10/202323:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/10/202314:00BWEquillium to Host Analyst & Investor Day
02/10/202314:00BWEquillium to Present at the JonesTrading 2023 Healthcare..
20/9/202314:00BWEquillium to Present at the Cantor Fitzgerald Global..
30/8/202314:00BWEquillium to Attend Wells Fargo Healthcare Conference &..
09/8/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:06EDGAR2Form 8-K - Current report
09/8/202322:01BWEquillium Reports Second Quarter 2023 Financial Results and..
02/8/202322:00BWEquillium Announces $7.5 Million Share Repurchase Program
01/6/202314:00BWEquillium to Present at the Jefferies Global Healthcare & LD..
15/5/202314:00BWEquillium Announces Poster Presentation at the Annual..
11/5/202322:01BWEquillium Reports First Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
EQ
Equillium
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés